Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2020-03-26 | 2020-05-08 | 109618 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2020-03-26 | 2020-04-09 | 109623 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2020-03-26 | 2020-05-29 | 109626 |
| TEVA-TOPILENE | 0.5MG | OINTMENT | Resolved | 2020-03-26 | 2020-10-08 | 109629 |
| TEVA-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-03-26 | 2021-04-15 | 109632 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2020-03-26 | 2020-09-24 | 109635 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2020-03-26 | 2020-07-10 | 109638 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2020-04-02 | 2020-05-21 | 110643 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-09-03 | 110646 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110649 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2020-04-02 | 2020-07-23 | 110652 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110655 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-04-02 | 2020-07-23 | 110661 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110664 |
| NOVAMOXIN | 250MG | CAPSULE | Resolved | 2020-04-02 | 2020-08-14 | 110667 |
| TEVA-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2020-04-02 | 2021-04-15 | 110670 |
| TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2020-04-02 | 2020-05-21 | 110673 |
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2020-04-02 | 2020-09-03 | 110676 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2020-04-02 | 2020-06-04 | 110679 |
| TEVA-DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-04-02 | 2020-04-16 | 110682 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |